PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice

Journal of Clinical Investigation

Volumn 122, Issue 11, 2012, Pages 4105-4117

  Iglesias, José ^a,b   Barg, Sebastian ^c,d   Vallois, David ^a   Lahiri, Shawon ^a   Roger, Catherine ^a   Yessoufou, Akadiri ^a   Pradevand, Sylvain ^a   McDonald, Angela ^d   Bonal, Claire ^e   Reimann, Frank ^f   Gribble, Fiona ^f   Debril, Marie Bernard ^a   Metzger, Daniel ^g   Chambon, Pierre ^g   Herrera, Pedro ^e   Rutter, Guy A ^d   Prentki, Marc ^b   Thorens, Bernard ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UPPSALA UNIVERSITY   (Sweden)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN KINASE D;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GOLGI COMPLEX; HYPERINSULINEMIA; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL;

ACTINS; ANIMALS; EXOCYTOSIS; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE; GOLGI APPARATUS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, MUTANT STRAINS; PPAR DELTA; PPAR-BETA; PROTEIN KINASE C;

EID: 84868626683     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI42127     Document Type: Article

References (59)

1. Lyssenko V, Groop L. Genome-wide association study for type 2 diabetes: clinical applications. Curr Opin Lipidol. 2009;20(2):87-91.
2. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378(9786):169-181.
3. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429(6987):41-46. (Pubitemid 38620543)
4. Inada A, et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A. 2008;105(50):19915-19919.
5. Rutter G. Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol Aspects Med. 2001;22(6):247-284. (Pubitemid 34223422)
6. Pørksen N, Hollingdal M, Juhl C, Butler P, Veldhuis JD, Schmitz O. Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes. 2002;51(suppl 1):S245-S254. (Pubitemid 34761523)
7. Cerasi E, Ependic S, Luft R. Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet. 1973;1(7807):794-797.
8. Pørksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia. 2002;45(1):3-20. (Pubitemid 34118538)
9. Shibasaki T, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci U S A. 2007;104(49):19333-19338.
10. Rorsman P, Renström E. Insulin granule dynamics in pancreatic beta cells. Diabetologia. 2003;46(8):1029-1045. (Pubitemid 37041234)
11. Kwan EP, et al. Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance. Diabetes. 2006;55(5):1421-1429. (Pubitemid 44195382)
12. Schonn JS, et al. Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells. Traffic. 2010;11(11):1415-1428.
13. Ivarsson R, Jing X, Waselle L, Regazzi R, Renström E. Myosin 5a controls insulin granule recruitment during late-phase secretion. Traffic. 2005;6(11):1027-1035. (Pubitemid 41472461)
14. Wang Z, Thurmond DC. Differential phosphorylation of RhoGDI mediates the distinct cycling of Cdc42 and Rac1 to regulate second-phase insulin secretion. J Biol Chem. 2010;285(9):6186-6197.
15. Wang Z, Oh E, Thurmond DC. Glucose-stimulated Cdc42 signaling is essential for the second phase of insulin secretion. J Biol Chem . 2007;282(13):9536-9546. (Pubitemid 47104622)
16. Wang Z, Thurmond DC. Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci. 2009;122(pt 7):893-903.
17. Sumara G, et al. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell. 2009;136(2):235-248.
18. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2008;29(3):351-366. (Pubitemid 351679704)
19. Prentki M, Madiraju SR. Glycerolipid/free fatty acid cycle and islet beta-cell function in health, obesity and diabetes. Mol Cell Endocrinol. 2012;353(1-2):88-100.
20. Itoh Y, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 2003;422(6928):173-176. (Pubitemid 36362750)
21. Gremlich S, et al. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology. 2005;146(1):375-382. (Pubitemid 40051761)
22. Gupta D, Jetton TL, Mortensen RM, Duan SZ, Peshavaria M, Leahy JL. In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter. J Biol Chem. 2008;283(47):32462-32470.
23. Cohen G, et al. Role of lipid peroxidation and PPAR-delta in amplifying glucose-stimulated insulin secretion. Diabetes. 2011;60(11):2830-2842.
24. Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology. 1998;139(6):2748-2754. (Pubitemid 28512383)
25. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996;137(1):354-366. (Pubitemid 26005011)
26. Di-Poï N, et al. Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development. Mol Cell Biol. 2005;25(5):1696-1712. (Pubitemid 40280138)
27. Tan N, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, Michalik L. The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration. Mol Cell Biol. 2007;27(20):7161-7175. (Pubitemid 47549752)
28. Varnat F, et al. PPARbeta/delta regulates paneth cell differentiation via controlling the hedgehog signaling pathway. Gastroenterology. 2006;131(2):538-553. (Pubitemid 44160696)
29. Kostadinova R, Wahli W, Michalik L. PPARs in diseases: control mechanisms of inflammation. Curr Med Chem. 2005;12(25):2995-3009. (Pubitemid 41672488)
30. Michalik L, Wahli W. PPARs mediate lipid signaling in inflammation and cancer. PPAR Res. 2008;2008:134059.
31. Riserus U, et al. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes. 2008;57(2):332-339.
32. Oliver WR Jr, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A. 2001;98(9):5306-5311.
33. Serrano-Marco L, et al. Activation of Peroxisome Proliferator-Activated Receptor-{beta}/-{delta} (PPAR-{beta}/-{delta}) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in Interleukin-6-stimulated adipocytes. Diabetes. 2011;60(7):1990-1999.
34. Wang Y, et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003;113(2):159-170. (Pubitemid 36514968)
35. Schuler M, et al. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. 2006;4(5):407-414. (Pubitemid 44645068)
36. Wan J, Jiang L, Lu Q, Ke L, Li X, Tong N. Activation of PPARdelta up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic beta-cells. Biochem Biophys Res Commun. 2010;391(3):1567-1572.
37. Ravnskjaer K, Frigerio F, Boergesen M, Nielsen T, Maechler P, Mandrup S. PPAR{delta} is a fatty acid sensor, which enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid induced dysfunction. J Lipid Res. 2010;51(6):1370-1379.
38. Bonal C, Thorel F, Ait-Lounis A, Reith W, Trumpp A, Herrera PL. Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adipocytes in mice. Gastroenterology. 2009;136(1):309-319.
39. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC. Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes. 2005;54(3):712-719. (Pubitemid 40322073)
40. Nguyen KT, et al. Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol Cell Biol. 2006;26(12):4511-4518.
41. Kang K, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008;7(6):485-495. (Pubitemid 351729204)
42. Odegaard J, et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008;7(6):496-507. (Pubitemid 351729205)
43. Arribas M, Regazzi R, Garcia E, Wollheim CB, De Camilli P. The stimulatory effect of rabphilin 3a on regulated exocytosis from insulin-secreting cells does not require an association-dissociation cycle with membranes mediated by Rab 3. Eur J Cell Biol. 1997;74(3):209-216. (Pubitemid 27490212)
44. Schluter OM, Khvotchev M, Jahn R, Sudhof TC. Localization versus function of Rab3 proteins. Evidence for a common regulatory role in controlling fusion. J Biol Chem. 2002;277(43):40919-40929. (Pubitemid 35215679)
45. Springett GM, Kawasaki H, Spriggs DR. Nonkinase second-messenger signaling: new pathways with new promise. Bioessays. 2004;26(7):730-738. (Pubitemid 38987607)
46. Thurmond D, Gonelle-Gispert C, Furukawa M, Halban PA, Pessin JE. Glucose-stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein) complex. Mol Endocrinol. 2003;17(4):732-742. (Pubitemid 36403583)
47. Tsuboi T, da Silva Xavier G, Leclerc I, Rutter GA. 5′ - AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics. J Biol Chem. 2003;278(52):52042-52051. (Pubitemid 38035789)
48. Nevins A, Thurmond DC. Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion. Am J Physiol Cell Physiol. 2003;285(3):C698-C710. (Pubitemid 37022068)
49. Bard F, Malhotra V. The formation of TGN-to-plasma-membrane transport carriers. Annu Rev Cell Dev Biol. 2006;22:439-455.
50. Hausser A, Storz P, Martens S, Link G, Toker A, Pfizenmaier K. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. Nat Cell Biol. 2005;7(9):880-886. (Pubitemid 41486288)
51. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 1997;138(4):1736-1741. (Pubitemid 27137129)
52. Rachdi L, et al. Differential effects of p27 in regulation of beta-cell mass during development, neonatal period, and adult life. Diabetes. 2006;55(12):3520-3528. (Pubitemid 44923613)
53. Joberty G, Stabila PF, Coppola T, Macara IG, Regazzi R. High affinity Rab3 binding is dispensable for Rabphilin-dependent potentiation of stimulated secretion. J Cell Sci. 1999;112(pt 20):3579-3587.
54. Mosedale M, Egodage S, Calma RC, Chi NW, Chessler SD. Neurexin-1alpha contributes to insulin-containing secretory granule docking. J Biol Chem. 2012;287(9):6350-6361.
55. Olofsson C, et al. Impaired insulin exocytosis in NCAM-/- mice due to defective reorganization of the submembrane F-actin network. Endocrinology. 2009;150(7):3067-3075.
56. Li J, O'Connor KL, Hellmich MR, Greeley GH Jr, Townsend CM Jr, Evers BM. The role of protein kinase D in neurotensin secretion mediated by protein kinase C-alpha/-delta and Rho/Rho kinase. J Biol Chem. 2004;279(27):28466-28474. (Pubitemid 38900128)
57. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999;21(1):70-71. (Pubitemid 29036285)
58. Gao N, White P, Doliba N, Golson ML, Matschinsky FM, Kaestner KH. Foxa2 controls vesicle docking and insulin secretion in mature Beta cells. Cell Metab. 2007;6(4):267-279. (Pubitemid 47450186)
59. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: a primary cell study. Cell Metab. 2008;8(6):532-539.